mhurhangee/ep-ind-claims huggingface dataset:
A system, comprising: an imaging device that captures an image of a tissue sample at an optical section of the tissue sample using Stimulated Raman Scattering, where the tissue sample has a thickness larger than the optical section; and a diagnostic module configured to receive the image for the tissue sample from the imaging device and generate a diagnosis for the tissue sample by applying a convolutional neural network to the image for classifying the tissue sample into categories including a tumoral tissue category or a nontumoral tissue category, where the tumoral tissue category is a tissue sample with a tumor and the nontumoral tissue category is a tissue sample without a tumor; wherein the diagnostic module generates a secondary diagnosis for the tissue sample by determining a quantitative measure of cellularity for the tissue sample in the image without machine learning and outputs the diagnosis when the secondary diagnosis matches the diagnosis for the tissue sample using the convolutional neural network but otherwise classifies the tissue sample in the non-diagnostic category when the secondary diagnosis does not match the diagnosis for the tissue sample using the convolutional neural network. an imaging device that captures an image of a tissue sample at an optical section of the tissue sample using Stimulated Raman Scattering, where the tissue sample has a thickness larger than the optical section; and a diagnostic module configured to receive the image for the tissue sample from the imaging device and generate a diagnosis for the tissue sample by applying a convolutional neural network to the image for classifying the tissue sample into categories including a tumoral tissue category or a nontumoral tissue category, where the tumoral tissue category is a tissue sample with a tumor and the nontumoral tissue category is a tissue sample without a tumor; wherein the diagnostic module generates a secondary diagnosis for the tissue sample by determining a quantitative measure of cellularity for the tissue sample in the image without machine learning and outputs the diagnosis when the secondary diagnosis matches the diagnosis for the tissue sample using the convolutional neural network but otherwise classifies the tissue sample in the non-diagnostic category when the secondary diagnosis does not match the diagnosis for the tissue sample using the convolutional neural network.
Window having a hardware groove, at least comprising: - an outer frame, to be connected to a building part, having a stop web (11.1) facing a building exterior and a window casement connected movably thereto, said window casement being openable towards a building interior and with a lip (21.3) being intended to be placed in a sealing manner against an inner visible face (11.3) of the outer frame; - a hardware unit, via which at least one bolt element is movable by means of a pushing element and is intended to be engaged with at least one bolt receiving element attached fixedly to a rebate face, wherein the pushing element is mounted in a hardware groove formed in a recessed manner with respect to a rebate face (11.4), wherein - the hardware unit and the pushing element are arranged with the bolt element in the outer frame, wherein the hardware groove is formed in a rebate face (11.4) on the inner periphery of the outer frame, and wherein - the bolt receiving element is arranged on a rebate face (21.4) on the outer periphery of the window casement, characterized in that the window casement is made from a plastics hollow profile, wherein the cross section of the window casement does not have a hardware groove, and at least one metal reinforcing profile has been inserted into a cavity that extends into a rebate lip (21.3). - an outer frame, to be connected to a building part, having a stop web (11.1) facing a building exterior and a window casement connected movably thereto, said window casement being openable towards a building interior and with a lip (21.3) being intended to be placed in a sealing manner against an inner visible face (11.3) of the outer frame; - a hardware unit, via which at least one bolt element is movable by means of a pushing element and is intended to be engaged with at least one bolt receiving element attached fixedly to a rebate face, wherein the pushing element is mounted in a hardware groove formed in a recessed manner with respect to a rebate face (11.4), wherein - the hardware unit and the pushing element are arranged with the bolt element in the outer frame, wherein the hardware groove is formed in a rebate face (11.4) on the inner periphery of the outer frame, and wherein - the bolt receiving element is arranged on a rebate face (21.4) on the outer periphery of the window casement, characterized in that the window casement is made from a plastics hollow profile, wherein the cross section of the window casement does not have a hardware groove, and at least one metal reinforcing profile has been inserted into a cavity that extends into a rebate lip (21.3).
A curable cyanoacrylate composition comprising: (i) a cyanoacrylate; and (ii) a thermoplastic polyurethane having a chain formed from structural units; wherein at least one of the structural units of the chain of the thermoplastic polyurethane (ii) has the formula: -O-R 1 -O-Ar-O-R 2 -O-, wherein: Ar is a C 6 -C 20 aromatic group with at least one aromatic ring; R 1 is a C 2 -C 10 alkyl group; and R 2 is a C 2 -C 10 alkyl group, and wherein the thermoplastic polyurethane (ii) is present in the curable cyanoacrylate composition from 1 wt% to 40 wt%, preferably from 2 wt% to 30 wt%, more preferably from 3 wt% to 20 wt%, and even more preferably from 5 wt% to 10 wt%, based on the total weight of the composition. (i) a cyanoacrylate; and (ii) a thermoplastic polyurethane having a chain formed from structural units; Ar is a C 6 -C 20 aromatic group with at least one aromatic ring; R 1 is a C 2 -C 10 alkyl group; and R 2 is a C 2 -C 10 alkyl group, and wherein the thermoplastic polyurethane (ii) is present in the curable cyanoacrylate composition from 1 wt% to 40 wt%, preferably from 2 wt% to 30 wt%, more preferably from 3 wt% to 20 wt%, and even more preferably from 5 wt% to 10 wt%, based on the total weight of the composition.
Polymer composition comprising - a first copolymer being an ethylene-propylene copolymer comprising from 60 to 95% by weight propylene and from 5 to 40% by weight ethylene, based on the total weight of the first copolymer, and - a copolymer blend comprising a second copolymer being a butylene-propylene copolymer, wherein the second copolymer comprises from 15 to 35% by weight 1-butylene and from 30 to 65% by weight propylene, based on the total weight of the second copolymer, wherein the weight ratio of the first copolymer to the copolymer blend ranges from 90:10 to 10:90, wherein the polymer composition has a softening temperature according to the Vicat method based on ASTM-D1525 of more than 120°C and a Young's modulus determined according to ISO 527-2 of less than 500 MPa, and wherein the polymer composition has DC electrical breakdown strength at room temperature determined according to ASTM D149-87 of higher than 300 kV/mm. - a first copolymer being an ethylene-propylene copolymer comprising from 60 to 95% by weight propylene and from 5 to 40% by weight ethylene, based on the total weight of the first copolymer, and - a copolymer blend comprising a second copolymer being a butylene-propylene copolymer, wherein
An aqueous composition for styling hair characterized in that it comprises a) one or more fatty substances, b) one or more waxes at a concentration of equal to or more than 20%, by weight, calculated to the total of the composition, c) one or more anionic surfactants and/or their salts according to the general structure wherein R 1 is a linear alkyl chain with C 6 to C 22, and R 2 is selected from H or linear alkyl chain with C 6 to C 12 with the provision that if R 2 is H then R 1 is selected from C 12 to C 22, d) one or more styling polymers. a) one or more fatty substances, b) one or more waxes at a concentration of equal to or more than 20%, by weight, calculated to the total of the composition, c) one or more anionic surfactants and/or their salts according to the general structure wherein R 1 is a linear alkyl chain with C 6 to C 22, and R 2 is selected from H or linear alkyl chain with C 6 to C 12 with the provision that if R 2 is H then R 1 is selected from C 12 to C 22, d) one or more styling polymers.
Method, comprising: - transmitting a radio transmission carrying audio data having a transmission power using a radio transmitter circuit connected to a corresponding antenna of a mobile electronic device; - measuring the power radiated by said antenna at said mobile electronic device; and - detecting if said measured radiated power exceeds a pre-determined upper limit based on regional legislation that is selected based on positioning data, cellular network connection data, a country setting and/or a Mobile Country Code of said mobile electronic device; - detecting passages in said audio data that have a local volume minimum; and - adjusting the power radiated by said antenna of the mobile electronic device, by decreasing the transmission power of the radio transmission when said measured radiated power exceeds the pre-determined upper limit; wherein said adjusting is performed during said detected passages that have a local volume minimum and wherein said adjusting comprises - adjusting the matching between said antenna and said radio transmitter circuit. - transmitting a radio transmission carrying audio data having a transmission power using a radio transmitter circuit connected to a corresponding antenna of a mobile electronic device; - measuring the power radiated by said antenna at said mobile electronic device; and - detecting if said measured radiated power exceeds a pre-determined upper limit based on regional legislation that is selected based on positioning data, cellular network connection data, a country setting and/or a Mobile Country Code of said mobile electronic device; - detecting passages in said audio data that have a local volume minimum; and - adjusting the power radiated by said antenna of the mobile electronic device, by decreasing the transmission power of the radio transmission when said measured radiated power exceeds the pre-determined upper limit; - adjusting the matching between said antenna and said radio transmitter circuit.
Method for monitoring the safety of a counterweighted elevator, characterized in that: - the elevator car is driven with the hoisting machine towards the top end of the elevator hoistway - contact between the counterweight and the end buffer of the elevator hoistway is determined - a reference point (R 1) for the location of the elevator car is registered when detecting contact between the counterweight and the end buffer - the distance (Δs) that the elevator car travels onwards from the aforementioned reference point (R 1) of the location is measured - if the distance (Δs) traveled by the elevator car onwards from the aforementioned reference point (R 1) exceeds a threshold value, a signal indicating a risk of slackening of the traction rope is formed. - the elevator car is driven with the hoisting machine towards the top end of the elevator hoistway - contact between the counterweight and the end buffer of the elevator hoistway is determined - a reference point (R 1) for the location of the elevator car is registered when detecting contact between the counterweight and the end buffer - the distance (Δs) that the elevator car travels onwards from the aforementioned reference point (R 1) of the location is measured - if the distance (Δs) traveled by the elevator car onwards from the aforementioned reference point (R 1) exceeds a threshold value, a signal indicating a risk of slackening of the traction rope is formed.
A method for producing RNA comprising the following steps: a) providing a template DNA comprising a nucleic acid sequence encoding an RNA sequence; b) in vitro transcription of the template DNA in order to obtain a composition comprising the RNA; wherein the method comprises at least the following steps for controlling the quality of the template DNA provided in step a): determining the concentration of the template DNA in a sample, determining the integrity of the template DNA, determining the identity of the template DNA, and determining the purity of the template DNA; wherein the RNA obtained in step b) is purified by at least one purification step in order to obtain purified RNA and wherein the at least one purification step comprises a chromatographic step, wherein the chromatographic step is an HPLC step; and wherein the template DNA is separated from the RNA obtained in step b) by using an oligo-dT-based affinity purification step. a) providing a template DNA comprising a nucleic acid sequence encoding an RNA sequence; b) in vitro transcription of the template DNA in order to obtain a composition comprising the RNA; determining the concentration of the template DNA in a sample, determining the integrity of the template DNA, determining the identity of the template DNA, and determining the purity of the template DNA;
A differential pressure regulating device comprising: a shunt having two ends and an adjustable flow regulating mechanism, the shunt being positionable in an atrial septum between a left atrium and a right atrium of a heart, with each end facing a respective atrium, the shunt being configured for enabling blood flow from the left atrium to the right atrium through the shunt, characterized in that the flow regulating mechanism provides a continuous opening to enable continual blood flow between the left atrium and the right atrium, and in that the device further comprises first and second pluralities of support arms (106, 211-216) adapted to support the shunt in the atrial septum, the first plurality of support arms being positionable in the left atrium and the second plurality of support arms being positionable in the right atrium. a shunt having two ends and an adjustable flow regulating mechanism, the shunt being positionable in an atrial septum between a left atrium and a right atrium of a heart, with each end facing a respective atrium, the shunt being configured for enabling blood flow from the left atrium to the right atrium through the shunt, characterized in that the flow regulating mechanism provides a continuous opening to enable continual blood flow between the left atrium and the right atrium, and in that the device further comprises first and second pluralities of support arms (106, 211-216) adapted to support the shunt in the atrial septum, the first plurality of support arms being positionable in the left atrium and the second plurality of support arms being positionable in the right atrium.
A computer-implemented method, comprising: receiving a computed tomography image of a patient; segmenting a first set of anatomical elements from the CT image; receiving a plurality of fluoroscopy images of the patient; segmenting a second set of anatomical elements from the plurality of fluoroscopy images; determining that a first anatomical element overlaps a second anatomical element, wherein the first anatomical element and the second anatomical element are elements of the second set of anatomical elements, defining a boundary around an area of overlap of the first anatomical element and the second anatomical element, detecting one or more gradient lines within a boundary of the second anatomical element in at least one of the plurality of fluoroscopy images, wherein the boundary of the second anatomical element is the boundary around an area of overlap of the first anatomical element and the second anatomical element, removing the detected gradient lines from the second anatomical element in the at least one of the plurality of fluoroscopy images, creating a registration between the CT image and the plurality of fluoroscopy images based on the segmented first set of anatomical elements and the second set of anatomical elements, wherein the segmenting results in identification of anatomical elements in the first and second set of anatomical elements, and wherein the identification is used to align a given anatomical element in the first set with the same anatomical element in the second set when creating the registration. receiving a computed tomography image of a patient; segmenting a first set of anatomical elements from the CT image; receiving a plurality of fluoroscopy images of the patient; segmenting a second set of anatomical elements from the plurality of fluoroscopy images; determining that a first anatomical element overlaps a second anatomical element, wherein the first anatomical element and the second anatomical element are elements of the second set of anatomical elements, defining a boundary around an area of overlap of the first anatomical element and the second anatomical element, detecting one or more gradient lines within a boundary of the second anatomical element in at least one of the plurality of fluoroscopy images, wherein the boundary of the second anatomical element is the boundary around an area of overlap of the first anatomical element and the second anatomical element, removing the detected gradient lines from the second anatomical element in the at least one of the plurality of fluoroscopy images, creating a registration between the CT image and the plurality of fluoroscopy images based on the segmented first set of anatomical elements and the second set of anatomical elements, wherein the segmenting results in identification of anatomical elements in the first and second set of anatomical elements, and wherein the identification is used to align a given anatomical element in the first set with the same anatomical element in the second set when creating the registration.
A medical support device (10; 20; 30; 40; 50; 60) for supporting a breast implant configured to be implanted in an individual and comprising an essentially flat back wall (11; 21; 31; 41; 51; 61), a curved front wall (13; 23; 33; 43; 53; 63) and a pocket (15; 25; 35; 65) defined between the back wall and the front wall for receiving a breast implant (17; 27; 37; 67) and/or tissue, wherein the back wall is configured to be implanted posterior to the front wall and essentially in the frontal plane of the individual, characterized in that the area of the back wall is substantially larger than the projected area of the front wall, and wherein at least part of the back wall is structured to extend outside the projected area of the front wall in an inferior direction and/or in a lateral direction and/or in a medial direction in the frontal plane of the individual, as seen in an implanted state.
A method for predicting risk of metastasis, overall survival, or both, in a patient with a primary cutaneous melanoma tumor, the method comprising: (a) measuring gene expression levels of at least eight genes selected from: BAP1_varA, BAP1 varB, MGP, SPP1, CXCL14, CLCA2, S100A8, BTG1, SAP130, ARG1, KRT6B, GJA1, ID2, EIF1B, S100A9, CRABP2, KRT14, ROBO1, RBM23, TACSTD2, DSC1, SPRR1B, TRIM29, AQP3, TYRP1, PPL, LTA4H, and CST6, in a sample of the primary cutaneous melanoma tumor, wherein the at least eight genes are: MGP, CXCL14, S100A8, BTG1, ARG1, GJA1, ID2, S100A9, KRT14, ROBO1, TACSTD2, SPRR1B, TRIM29, and TYRP1; wherein measuring gene expression levels of the at least eight genes comprises measurement of a level of fluorescence by a sequence detection system following RT-PCR of the at least eight genes; (b) determining a patient gene-expression profile signature comprising the gene expression levels of the at least eight genes; (c) comparing the patient gene-expression profile signature to a gene-expression profile of a predictive training set; and (d) providing an indication as to a risk of metastasis, overall survival or both for the primary cutaneous melanoma tumor when the patient gene expression profile indicates that the expression levels of at the least eight genes are altered in a predictive manner as compared to the gene expression profile of the predictive training set. (a) measuring gene expression levels of at least eight genes selected from: BAP1_varA, BAP1 varB, MGP, SPP1, CXCL14, CLCA2, S100A8, BTG1, SAP130, ARG1, KRT6B, GJA1, ID2, EIF1B, S100A9, CRABP2, KRT14, ROBO1, RBM23, TACSTD2, DSC1, SPRR1B, TRIM29, AQP3, TYRP1, PPL, LTA4H, and CST6, in a sample of the primary cutaneous melanoma tumor, wherein the at least eight genes are: MGP, CXCL14, S100A8, BTG1, ARG1, GJA1, ID2, S100A9, KRT14, ROBO1, TACSTD2, SPRR1B, TRIM29, and TYRP1; wherein measuring gene expression levels of the at least eight genes comprises measurement of a level of fluorescence by a sequence detection system following RT-PCR of the at least eight genes; wherein the at least eight genes are: MGP, CXCL14, S100A8, BTG1, ARG1, GJA1, ID2, S100A9, KRT14, ROBO1, TACSTD2, SPRR1B, TRIM29, and TYRP1; wherein measuring gene expression levels of the at least eight genes comprises measurement of a level of fluorescence by a sequence detection system following RT-PCR of the at least eight genes; (b) determining a patient gene-expression profile signature comprising the gene expression levels of the at least eight genes; (c) comparing the patient gene-expression profile signature to a gene-expression profile of a predictive training set; and (d) providing an indication as to a risk of metastasis, overall survival or both for the primary cutaneous melanoma tumor when the patient gene expression profile indicates that the expression levels of at the least eight genes are altered in a predictive manner as compared to the gene expression profile of the predictive training set.
A liquid concentrate comprising dissolved prohexadione in a ionic liquid, the ionic liquid comprising an organic base and a strong acid, wherein the organic base is an amine, imine or amide, wherein the strong acid has a pKa of below 4 and is able to form a ionic liquid with the organic base.
A fixture for use with an engraver of the type including a tool moveable along a horizontal axis for serially engraving a plurality of serially arranged cylindrical objects wherein said fixture comprises: a base alignable with said horizontal axis; a plurality of object receiving stations (14a, 14b, 14c, 14d) arranged in series along said axis, each said station (14a, 14b, 14c, 14d) including a drive structure and a slave structure, the drive and slave structures being spaced from one another along said horizontal axis; each drive structure comprising drive wheels for rotating an object thereon; said slave structure having slave wheels adapted to support an object in concert with said drive wheels; and a drive system including a motor with an output shaft gang-connected to said drive wheels for synchronously incrementally rotating all of said drive wheels between linear passes of said engraving tool during an engraving process. a base alignable with said horizontal axis; a plurality of object receiving stations (14a, 14b, 14c, 14d) arranged in series along said axis, each said station (14a, 14b, 14c, 14d) including a drive structure and a slave structure, the drive and slave structures being spaced from one another along said horizontal axis; each drive structure comprising drive wheels for rotating an object thereon; said slave structure having slave wheels adapted to support an object in concert with said drive wheels; and a drive system including a motor with an output shaft gang-connected to said drive wheels for synchronously incrementally rotating all of said drive wheels between linear passes of said engraving tool during an engraving process.